These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6332448)

  • 1. Attempts to suppress experimental allergic neuritis in the rat by pretreatment with antigen.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    Acta Neuropathol; 1984; 64(2):153-60. PubMed ID: 6332448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo monoclonal antibody treatment with Ox19 (anti-rat CD5) causes disease relapse and terminates P2-induced immunospecific tolerance in experimental allergic neuritis.
    Strigård K; Larsson P; Holmdahl R; Klareskog L; Olsson T
    J Neuroimmunol; 1989 Jun; 23(1):11-8. PubMed ID: 2470777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attempts to transfer experimental allergic neuritis with lymphocytes.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    J Neuroimmunol; 1984; 6(6):373-85. PubMed ID: 6480819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement depletion suppresses Lewis rat experimental allergic neuritis.
    Feasby TE; Gilbert JJ; Hahn AF; Neilson M
    Brain Res; 1987 Sep; 419(1-2):97-103. PubMed ID: 3499953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum.
    Harvey GK; Pollard JD
    J Neuroimmunol; 1992 Dec; 41(2):159-66. PubMed ID: 1334966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of experimental allergic neuritis in the Lewis rat with bovine P2 protein.
    Cunningham JM; Powers JM; Brostoff SW
    Brain Res; 1983 Jan; 258(2):285-9. PubMed ID: 6186335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation in experimental interstitial nephritis: immunization with renal tubular antigen in incomplete Freund's adjuvant induces major histocompatibility complex-restricted, OX8+ suppressor T cells which are antigen-specific and inhibit the expression of disease.
    Kelly CJ; Clayman MD; Neilson EG
    J Immunol; 1986 Feb; 136(3):903-7. PubMed ID: 2416839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN.
    Wang YZ; Liang QH; Ramkalawan H; Zhang W; Zhou WB; Xiao B; Tian FF; Yang H; Li J; Zhang Y; Xu NA
    Immunol Invest; 2012; 41(2):171-82. PubMed ID: 21864114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P0 myelin protein produces experimental allergic neuritis in Lewis rats.
    Milner P; Lovelidge CA; Taylor WA; Hughes RA
    J Neurol Sci; 1987 Jul; 79(3):275-85. PubMed ID: 2440998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections.
    Oldham G
    Res Vet Sci; 1983 Mar; 34(2):240-4. PubMed ID: 6856998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neurotrophic analogue of ACTH4-9 protects against experimental allergic neuritis.
    Duckers HJ; Verhaagen J; Gispen WH
    Ann N Y Acad Sci; 1993 May; 680():493-5. PubMed ID: 8390175
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of myelin P2 protein in the production of experimental allergic neuritis.
    Rostami A; Brown MJ; Lisak RP; Sumner AJ; Zweiman B; Pleasure DE
    Ann Neurol; 1984 Dec; 16(6):680-5. PubMed ID: 6084458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of injection route and adjuvant ratio in antigen emulsion on antibody production].
    Sonezaki I
    Hokkaido Igaku Zasshi; 1986 Mar; 61(2):235-43. PubMed ID: 2424816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
    Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
    Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
    Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
    J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis.
    Mausberg AK; Szepanowski F; Odoardi F; Flügel A; Kleinschnitz C; Stettner M; Kieseier BC
    J Neuroinflammation; 2018 Aug; 15(1):217. PubMed ID: 30068351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effect of FK506 on experimental allergic neuritis in Lewis rats: change of T cell subsets.
    Adachi A; Araga S; Takahashi K
    Intern Med; 1992 Jan; 31(1):6-10. PubMed ID: 1373661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.